Mineralocorticoid receptor antagonists (MRA) exert anti-atherosclerotic properties in vivo through their combined effects on various cells and tissues. We previously found a significant interaction between TNFα-induced inflammatory pathways and mineralocortic... ...

请注册登录后继续浏览